alexa The Function Role of SDF-1/CXCR4 Signaling in Osteoarthritis | Open Access Journals
ISSN: 2161-1149
Rheumatology: Current Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

The Function Role of SDF-1/CXCR4 Signaling in Osteoarthritis

Xiaochun Wei1, Pengcui Li1, Congming Zhang1, Chongwei Chen1and Lei Wei1,2*

1Department of Orthopaedics, The Second Hospital of Shanxi Medical University, Shanxi Key Lab of Bone and Soft Tissue Injury Repair, Taiyuan, China

2Department of Orthopaedics, Warren Alpert Medical School of Brown University, CORO West, Suite 402A, 1 Hoppin Street, Providence RI 02903, USA

*Corresponding Author:
Lei Wei
Department of Orthopaedics, Warren Alpert Medical School of Brown University
CORO West, Suite 402A, 1 Hoppin Street, Providence RI- 02903, USA
E-mail: [email protected] or [email protected]

Received Date: December 13, 2012; Accepted Date: December 14, 2012; Published Date: December 24, 2012

Citation: Wei X, Li P, Zhang C, Chen C, Wei L (2012) The Function Role of SDF-1/CXCR4 Signaling in Osteoarthritis. Rheumatol Curr Res 2:e111. doi: 10.4172/2161-1149.1000e111

Copyright: © 2012 Wei X, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Rheumatology: Current Research

Osteoarthritis (OA) is the most common cause of disability in the elderly [1]. Disability stems from the pain, stiffness, inflammation and limitations in mobility imparted by the degeneration of the articular cartilage that is trademarks of the disease. Unfortunately, current pharmacological therapy aimed at the mechanism of disease is relatively ineffective, largely because the etiology and pathogenesis of OA remain unknown.

Chemokines and their receptors are important in immune cell function, migration of stem cells, and regulation of cancer cell invasion. There are four groups of chemokine receptors: C, CC, CXC, and CX3C. Chemokine Receptor Four (CXCR4) is a seven-transmembrane G-protein-coupled receptor, whose activation leads to intracellular signaling cascades, downstream targets of which include MMP1 and VEGF [2,3]. The ligand for CXCR4 is the chemokine Stromal Cell Derived Factor One (SDF1) [4]. SDF-1 is an 8 KDa chemokine originally isolated from a bone marrow stromal cell line [5]. Although the mechanism of its release remains unknown, it appears to be related to the inflammatory cytokines IL-1β and TNF-α [6,7] . SDF-1 activates a wide variety of primary cells by binding to its specific receptor, CXCR4 to stimulate proliferation, differentiation, and apoptosis [8,9].

Recently, Kanbe and his colleagues found an interesting distribution pattern between SDF-1 and CXCR4 in human joint. Their studies show that SDF1 is primarily present in the articular chondrocytes in joints, and its receptor CXCR4 is present in the synovial membrane cells [10] which would allow these two molecules to participate in a paracrine regulatory mechanism allowing for induction of MMPs release. In chondrocytes, SDF-1 activates the calcium, Erk and p38 MAP kinase signaling pathways, thereby inducing the release of Matrix Metalloproteinase (MMPs) and other proteins [11-13]. In contrast, synovectomy, a surgical procedure that effectively relieves pain in OA patients, reduces circulating serum SDF-1 levels, thereby decreasing the release of MMPs from joint cartilage [14]. These studies suggest that SDF-1/CXCR4 singling is a key regulator of cartilage degradation during OA pathogenesis [10,11,14,15]. Studies have also demonstrated that SDF-1 and its receptor CXCR4 play an important role in growth plate development. CXCR4/SDF1 promotes chondrocyte hypertrophy in the chondro-osseous junction during endochondral bone formation by mediating type X and MMP-13, which are classic markers of hypertrophic chondrocyte differentiation [16]. Overexpress chemokine SDF-1 results in rabbit growth plate closure [17]. All of these findings support the notion that elevated SDF-1/CXCR4 signaling in the joint may contribute significantly to cartilage matrix degeneration, and its inhibition could reduce this damage.

Development of agents that block CXCR4 has been propelled by the fact that it is a co-receptor for the human immunodeficiency virus. The drug AMD3100, a specific inhibitor of SDF-1 pathway, is a bicyclam with high specificity for CXCR4 and is the prototypical CXCR4 blocking drug [18]. It is already approved for human use. In chondrosarcoma cells, CXCR4 blockade with AMD3100 inhibits expression of MMP1 and invasion in vitro [19]. AMD3100 has been shown to inhibit collagen-induced joint inflammation [20]. Recently, Wei and his colleagues have demonstrated that attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway in primary guinea pig OA model [21]. CXCR4, therefore, is an attractive target since it is over-expressed in OA cartilage chondrocytes. Blocking SDF1/CXCR4 signaling pathway is a novel therapeutic target for the prevention and treatment of osteoarthritis.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 11696
  • [From(publication date):
    December-2012 - Oct 23, 2017]
  • Breakdown by view type
  • HTML page views : 7909
  • PDF downloads :3787
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords